Biofidelity: Lee Newcomer

Biofidelity has added Lee Newcomer to its scientific advisory board. Newcomer is an oncologist who joins the rest of the board in helping guide the development and launch of Biofidelity's Aspyre technology, an enzymatic diagnostic method for identifying DNA mismatches. 

Newcomer previously served as senior vice president for oncology and genetics at United Healthcare and as CMO and senior vice president of health policy and strategy at UnitedHealth Group. Newcomer practiced medical oncology for nine years prior to working with UnitedHealth Group and is a former chairman of Park Nicollet Health Services.